SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039350
Filing Date
2023-08-08
Accepted
2023-08-08 07:07:10
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-20230630.htm   iXBRL 10-Q 2908226
2 EX-31.1 crnx-ex31_1.htm EX-31.1 38184
3 EX-31.2 crnx-ex31_2.htm EX-31.2 38143
4 EX-32.1 crnx-ex32_1.htm EX-32.1 12057
  Complete submission text file 0000950170-23-039350.txt   10941160

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crnx-20230630_def.xml EX-101.DEF 197642
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20230630_pre.xml EX-101.PRE 339518
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20230630_lab.xml EX-101.LAB 451958
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20230630.xsd EX-101.SCH 49686
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crnx-20230630_cal.xml EX-101.CAL 47950
60 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20230630_htm.xml XML 2449447
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 231149266
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences